MSD Animal Health, PO Box 31, 5830 AA Boxmeer, the Netherlands.
Quality Milk Management Services Ltd., Cedar Barn, Easton Hill, Easton, Wells, Somerset, BA5 1DU, United Kingdom.
J Dairy Sci. 2021 Aug;104(8):9063-9081. doi: 10.3168/jds.2020-19258. Epub 2021 Apr 30.
Selective use of antibiotic dry cow treatment can be implemented at the cow or quarter level, with the latter having the potential to further reduce antibiotic use. Our objective was to compare these 2 approaches in 6 herds in the United Kingdom in which environmental mastitis predominated. Eight hundred seven cows were enrolled and categorized as having a high cell count (n = 401) or low cell count (n = 406) in the last 3 mo of lactation and clinical mastitis history. All quarters of all enrolled cows received an internal teat sealant. Within each category, cows were randomly allocated to 1 of 3 groups; in one group antibiotic treatment was allocated at cow level (i.e., all 4 quarters received antibiotic), whereas in the 2 remaining groups antibiotic treatment was allocated at quarter level, based on California Mastitis Test (CMT) findings. Two different thresholds, score 1 and 2, were used to determine likely infection status. Quarter milk samples were collected at dry off and postcalving for bacteriological culture and somatic cell count (SCC). Cows were monitored for clinical mastitis from dry off until 100 d in milk. Cow level SCC and milk yield data were collated from farm records. Within each category, the 2 quarter level treatment groups were compared with cow level treatment at dry off. Leaving quarters untreated with intramammary antibiotic in cows in the high cell count group, with a CMT <2 or <1, reduced antibiotic use by 55% and 31%, respectively, and resulted in no difference in the odds of being infected with any pathogen postcalving, but was associated with a higher SCC at the first test day. Intramammary antibiotic treatment of quarters with a CMT ≥1 in cows in the low cell count category at dry off was not associated with any reduction in the odds of being infected with a major pathogen postcalving but was associated with a decrease in the odds of being infected with a minor mastitis pathogen postcalving. The use of antibiotics in quarters of cows categorized as low cell count at dry off, increased the proportion of quarters treated with antibiotic from 0% at cow level to 31% (CMT ≥ 1) and 12% (CMT ≥ 2) at quarter level, only resulting in a reduction in SCC of around 20,000 cells/mL at the first test day, if all quarters with CMT score ≥1 were treated with antibiotic. No differences in clinical mastitis incidence and milk yield in the first 100 d in milk were detected between any of the treatment groups. These study findings support selective quarter level dry off treatment only in cows with cow level SCC >200,000 cells/mL at dry off.
选择使用抗生素干奶牛治疗可以在奶牛或牛舍水平上实施,后者有可能进一步减少抗生素的使用。我们的目的是在英国的 6 个以环境性乳腺炎为主的牛群中比较这 2 种方法。807 头奶牛被纳入研究,并根据泌乳最后 3 个月的细胞计数(高细胞计数组 n = 401,低细胞计数组 n = 406)和临床乳腺炎病史进行分类。所有入组奶牛的所有乳头均接受了内部乳头密封剂。在每个类别中,奶牛随机分配到 3 个组中的 1 个;在 1 个组中,所有 4 个乳头都接受抗生素治疗(即所有乳头都接受抗生素治疗),而在其余 2 个组中,根据加利福尼亚乳房炎测试(CMT)的结果,抗生素治疗在牛舍水平上进行分配。使用 2 个不同的阈值(评分 1 和 2)来确定可能的感染状态。在干奶和产后收集乳头奶样进行细菌培养和体细胞计数(SCC)。从干奶到产奶 100 天,奶牛被监测临床乳腺炎。从农场记录中整理牛舍水平 SCC 和牛奶产量数据。在每个类别中,与干奶时的牛舍水平治疗相比,比较 2 个牛舍水平治疗组。在高细胞计数组中,CMT<2 或<1 的奶牛不使用乳头内抗生素治疗,可分别减少 55%和 31%的抗生素使用,并降低产后任何病原体感染的可能性,但在首次检测日时 SCC 较高。在低细胞计数组中,CMT≥1 的奶牛在干奶时接受乳头内抗生素治疗与产后主要病原体感染的可能性降低无关,但与产后轻度乳腺炎病原体感染的可能性降低有关。在干奶时归类为低细胞计数的奶牛的乳头中使用抗生素,会使接受抗生素治疗的乳头比例从牛舍水平的 0%增加到 31%(CMT≥1)和 12%(CMT≥2),只有在首次检测日时 SCC 降低约 20,000 个细胞/mL,如果所有 CMT 评分≥1 的乳头都接受抗生素治疗。在任何治疗组中,都未检测到产奶前 100 天的临床乳腺炎发病率和牛奶产量有差异。这些研究结果支持仅在干奶时牛舍水平 SCC>200,000 个细胞/mL 的奶牛中进行选择的牛舍水平干奶治疗。